TY - JOUR
T1 - The Gut Microbiome Modifies the Association between a Mediterranean Diet and Diabetes in USA Hispanic/ Latino Population
AU - Wang, Dong D.
AU - Qi, Qibin
AU - Wang, Zheng
AU - Usyk, Mykhaylo
AU - Sotres-Alvarez, Daniela
AU - Mattei, Josiemer
AU - Tamez, Martha
AU - Gellman, Marc D.
AU - Daviglus, Martha
AU - Hu, Frank B.
AU - Stampfer, Meir J.
AU - Huttenhower, Curtis
AU - Knight, Rob
AU - Burk, Robert D.
AU - Kaplan, Robert C.
N1 - Funding Information:
The Hispanic Community Health Study-Study of Latinos (HCHS-SOL) is a collaborative study supported by contracts from the National Heart, Lung, and Blood Institute (NHLBI) to the University of North Carolina (HHSN268201300001I/ N01-HC-65233), University of Miami (HHSN268201300004I/ N01-HC-65234), Albert Einstein College of Medicine (HHSN268201300002I/N01-HC-65235), University of Illinois at Chicago (HHSN268201300003I/N01-HC-65236 Northwestern Univ), and San Diego State University (HHSN268201300005I/ N01-HC-65237). The following Institutes/Centers/Offices have contributed to the HCHS/SOL through a transfer of funds to the NHLBI: National Institute on Minority Health and Health Disparities, National Institute on Deafness and Other Communication Disorders, National Institute of Dental and Craniofacial Research, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Neurological Disorders and Stroke, NIH Institution-Office of Dietary Supplements. Additional funding for the "Gut Origins of Latino Diabetes" (GOLD) ancillary study to HCHS-SOL was provided by R01MD011389 from the National Institute on Minority Health and Health Disparities. Dr. Dong D. Wang's research is supported by R01NR019992 from the National Institute of Nursing Research, R00DK119412 from NIDDK and a Pilot and Feasibility award from the Boston Nutrition and Obesity Center funded by the NIDDK (P30DK046200). None of the funding agencies had a role in the design, conduct, interpretation, or reporting of this study
Publisher Copyright:
© 2021 The Author(s) 2021.
PY - 2022/3/1
Y1 - 2022/3/1
N2 - Context: The interrelationships among the gut microbiome, the Mediterranean diet (MedDiet), and a clinical endpoint of diabetes is unknown. Objective: To identify gut microbial features of a MedDiet and examine whether the association between MedDiet and diabetes varies across individuals with different gut microbial profiles. Methods: This study included 543 diabetic, 805 prediabetic, and 394 normoglycemic participants from a cohort study of USA Hispanic/Latino men and women. Fecal samples were profiled using 16S rRNA gene sequencing. Adherence to MedDiet was evaluated by an index based on 2 24-hour dietary recalls. Results: A greater MedDiet adherence was associated with higher abundances of major dietary fiber metabolizers (e.g., Faecalibacterium prausnitzii, false-discovery-rate-adjusted P [q] = 0.01), and lower abundances of biochemical specialists (e.g., Parabacteroides, q = 0.04). The gut microbiomes of participants with greater MedDiet adherence were enriched for functions involved in dietary fiber degradation but depleted for those related to sulfur reduction and lactose and galactose degradation. The associations between MedDiet adherence and diabetes prevalence were significantly stronger among participants with depleted abundance of Prevotella (pinteraction = 0.03 for diabetes, 0.02 for prediabetes/diabetes, and 0.02 for prediabetes). A 1-SD deviation increment in the MedDiet index was associated with 24% (odds ratio [OR] 0.76; 95% CI, 0.59-0.98) and 7% (OR 0.93; 95% CI, 0.72-1.20) lower odds of diabetes in Prevotella noncarriers and carriers, respectively. Conclusion: Adherence to MedDiet is associated with diverse gut microorganisms and microbial functions. The inverse association between the MedDiet and diabetes prevalence varies significantly depending on gut microbial composition.
AB - Context: The interrelationships among the gut microbiome, the Mediterranean diet (MedDiet), and a clinical endpoint of diabetes is unknown. Objective: To identify gut microbial features of a MedDiet and examine whether the association between MedDiet and diabetes varies across individuals with different gut microbial profiles. Methods: This study included 543 diabetic, 805 prediabetic, and 394 normoglycemic participants from a cohort study of USA Hispanic/Latino men and women. Fecal samples were profiled using 16S rRNA gene sequencing. Adherence to MedDiet was evaluated by an index based on 2 24-hour dietary recalls. Results: A greater MedDiet adherence was associated with higher abundances of major dietary fiber metabolizers (e.g., Faecalibacterium prausnitzii, false-discovery-rate-adjusted P [q] = 0.01), and lower abundances of biochemical specialists (e.g., Parabacteroides, q = 0.04). The gut microbiomes of participants with greater MedDiet adherence were enriched for functions involved in dietary fiber degradation but depleted for those related to sulfur reduction and lactose and galactose degradation. The associations between MedDiet adherence and diabetes prevalence were significantly stronger among participants with depleted abundance of Prevotella (pinteraction = 0.03 for diabetes, 0.02 for prediabetes/diabetes, and 0.02 for prediabetes). A 1-SD deviation increment in the MedDiet index was associated with 24% (odds ratio [OR] 0.76; 95% CI, 0.59-0.98) and 7% (OR 0.93; 95% CI, 0.72-1.20) lower odds of diabetes in Prevotella noncarriers and carriers, respectively. Conclusion: Adherence to MedDiet is associated with diverse gut microorganisms and microbial functions. The inverse association between the MedDiet and diabetes prevalence varies significantly depending on gut microbial composition.
KW - Diabetes
KW - Diet
KW - Microbiome
UR - http://www.scopus.com/inward/record.url?scp=85121642169&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85121642169&partnerID=8YFLogxK
U2 - 10.1210/clinem/dgab815
DO - 10.1210/clinem/dgab815
M3 - Article
C2 - 34747479
AN - SCOPUS:85121642169
SN - 0021-972X
VL - 107
SP - E924-E934
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 3
ER -